BioSpace News Archive

The Board of Directors of Regional Center of Orange County has appointed Tustin’s Frances M.K. Hernandez to serve a one-year term on the organization’s unpaid volunteer board, beginning January 1, 2020

Rotary and the Bill & Melinda Gates Foundation are renewing their longstanding partnership to end polio, announcing a joint commitment of up to $450 million to support the global polio eradication effort.

Advanced BioDesign, a French pre-clinical stage biotechnology company focused on the development of a new treatment against resistant cancers, today announces it has teamed up with 27 European academic and industrial organizations from 11 countries to form the multidisciplinary science consortium, ENHPATHY.

Today, Toxys announces the appointment of a Chief Business Officer (CBO) and a Chief Operating Officer (COO).

Technavio has announced its latest market research report titled global blister packaging machinery market 2020-2024.

BetterLife Pharma Inc. announced that it has made changes to its Board of Directors and Management to prepare for its next growth phase and launch of products in the United States.

ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced that Cara Cassino, MD, Chief Medical Officer and Executive Vice President of Research has been invited to discuss the potential role of DLAs

DaVita is closing the decade by highlighting its milestones and achievements from 2019.

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXD), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announced today that it will present at the “Frontiers in Academic Pathology” symposium, hosted by the Icahn School of Medicine at Mount Sinai, to be held on Friday, January 31, 2020

CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader specializing in blood purification, highlights the recent publication entitled, “Hemoadsorption Improves Survival of Rats Exposed to an Acutely Lethal Dose of Aflatoxin B1" in the journal, Scientific Reports, a Nature Research publication.